Press release
Global Scleroderma Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Scleroderma
How Big Is the Scleroderma Market Size Expected to Be by 2034?
In the past few years, the scleroderma market has shown robust growth. It is projected to expand from $2.33 billion in 2024 to $2.49 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the historic period include strides taken in diagnosis, immunology research, developments in therapy, increased awareness and education, and explorations in genetic studies.
The market for scleroderma is predicted to experience robust expansion in the upcoming years, swelling to a worth of $3.25 billion by 2029, with a 6.9% compound annual growth rate (CAGR). This anticipated growth during the forecast period can largely be attributed to biological therapies, precision medicine, stem cell therapies, as well as genomic and biomarker research, and worldwide collaborations. The major trends expected during this period are digital health solutions, emphasis on the microbiome, patient-focused care, regenerative medicine, as well as health equity and accessibility.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12615
What Are the Emerging Segments Within the Scleroderma Market?
The scleroderma market covered in this report is segmented -
1) By Treatment: Medication, Surgery, Other Treatments
2) By Indication: Systemic Scleroderma, Localized Scleroderma
3) By End User: Hospital, Pharmaceutical Stores, Other End Users
Subsegments:
1) By Medication: Immunosuppressants, Antifibrotic Agents, Vasodilators, Corticosteroids, Pain Relievers
2) By Surgery: Lung Transplantation, Other Surgical Interventions
3) By Other Treatments: Physical Therapy, Occupational Therapy, Lifestyle Modifications, Alternative Therapies
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12615&type=smp
What Long-Term Drivers Are Shaping Scleroderma Market Trends?
The escalating incidence of scleroderma is fuelling progress in the scleroderma market. Characterized by abnormal collagen growth, a vital protein forming the basis of skin and other tissues, scleroderma is a chronic autoimmune disease. It results from a misregulated immune response that may be spurred by diverse environmental aspects, leading to the disease's manifestation. As the case count augments, the necessity for enhanced diagnostic and therapeutic strategies becomes clear. Scleroderma therapies play an imperative role in disease control and symptom relief, by manipulating the immune response and reducing the impact of environmental hazards. For example, Karger Publishers, a Swiss firm specializing in peer-reviewed journals, stated in June 2022, about 19,000 scleroderma cases existed in the UK, with 2.5 million cases recorded worldwide. Additionally, a study released in August 2024 by Oxford Academic Press, a university press run by the UK's University of Oxford, discovered 1,588 cases of systemic sclerosis (SSc) amongst 10.1 million individuals in the CPRD, which paved the way for diagnosing 206 cancers, mainly mucocutaneous (4.5%), lung (2.1%), and breast (1.9%). Consequently, this increase in scleroderma cases fuels growth in the scleroderma market.
Who Are the Top Competitors in Key Scleroderma Market Segments?
Major companies operating in the scleroderma market include Pfizer Inc., Johnson And Johnson Inc., F. Hoffmann-La Roche AG, Abbvie Inc., Bayer AG, Novartis AG, Merck And Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., GSK plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Aspen Pharmacare Holdings Limited, Boehringer Ingelheim International GmbH, Principia Biopharma Corp, aTyr Pharma Inc., Cumberland Pharmaceuticals Inc., Kadmon Holdings Inc., Emerald Health Pharmaceuticals Inc., FibroGen Inc., Argentis Pharmaceuticals LLC, Corbus Pharmaceuticals Holdings Inc., H.A.C. Pharma
What Scleroderma Market Trends Are Gaining Traction Across Different Segments?
The growing trend for developing innovative treatments is being witnessed in the scleroderma market. Key players in this market are focusing on creating unique drugs to help control symptoms and remain competitive. For example, Tyr Pharma Inc., a biopharmaceutical company based in the US, recently achieved regulatory approval from US Food and Drug Administration for its innovative drug efzofitimod, meant for systemic sclerosis-related interstitial lung disease, in April 2022. This new medication is classified as a first-in-class immunomodulator, which controls immune response by moderating the neuropilin-2 (NRP2) receptor, thereby decreasing scleroderma symptoms. Moreover, Efzofitimod also targets identical immune cells that induce SSc-ILD (Interstitial lung disease connected with systemic sclerosis) and pulmonary sarcoidosis, resulting in lower pro-inflammatory markers in a clinical trial involving patients with pulmonary sarcoidosis.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/scleroderma-global-market-report
Which Regions Are Becoming Hubs for Scleroderma Market Innovation?
North America was the largest region in the scleroderma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleroderma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Scleroderma Market?
2. What is the CAGR expected in the Scleroderma Market?
3. What Are the Key Innovations Transforming the Scleroderma Industry?
4. Which Region Is Leading the Scleroderma Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Scleroderma Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities here
News-ID: 4001426 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Scleroderma
Rising Scleroderma Cases Propel Therapeutics Demand: The Driving Engine Behind S …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Scleroderma Market Size Growth Forecast: What to Expect by 2025?
The overall volume of the scleroderma market has shown robust expansion throughout the recent past, projecting an increase from its 2024 valuation of $2.33 billion to reach $2.48 billion by 2025, reflecting a compound annual growth rate (CAGR) of…
Key Factor Supporting Scleroderma Market Development in 2025: Rising Scleroderma …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Scleroderma Market Size By 2025?
The market size of scleroderma has notably expanded in past years. It is projected to rise from a value of $2.33 billion in 2024 up to $2.49 billion in 2025, posting a compound annual growth rate (CAGR) of 6.9%. The…
Scleroderma Market Trends, Size, Share And Analysis 2024-2033
"The new report published by The Business Research Company, titled Scleroderma Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the scleroderma market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to…
Scleroderma Therapeutics Market, By Indication (Localized Scleroderma, Systemic …
Scleroderma therapeutics market size is projected to grow at a compound annual growth rate of 5.7% over the forecast period of 2021 to 2028. Data Bridge Market Research report on scleroderma therapeutics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market's growth.
View Detailed Report: https://www.databridgemarketresearch.com/reports/global-scleroderma-therapeutics-market
Scleroderma is a rare auto-immune disease which is generally characterized by…
Scleroderma Therapeutics Market, By Indication (Localized Scleroderma, Systemic …
Scleroderma therapeutics market size is projected to grow at a compound annual growth rate of 5.7% over the forecast period of 2021 to 2028. Data Bridge Market Research report on scleroderma therapeutics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecasted period while providing their impacts on the market's growth.
View Detailed Report: https://www.databridgemarketresearch.com/reports/global-scleroderma-therapeutics-market
Scleroderma is a rare auto-immune disease which is generally characterized by…
Scleroderma Therapeutics Market Analysis - Forecast to 2026
As per the research conducted by GME, the Global Scleroderma Therapeutics Market will grow with a CAGR value of 6.1 percent. Moreover, the rising R&D activities along with the advancing technology and increasing government spending in the pharma industry has boosted the market and growth will be seen in the future.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Scleroderma Therapeutics Market…
